Comparative Analysis of Abbreviated and Full Protocol MRI in Detecting Axillary Lymph Node Metastasis in Patients with Known Breast Cancer Abbreviated MRI in Axilla
Abstract
Background: Accurate axillary lymph node staging is crucial for breast cancer prognosis and treatment planning. This study compares the diagnostic efficacy of abbreviated MRI (AB-MRI) protocols with limited sequences and reduced time, against full-diagnostic MRI (FD-MRI) in staging axillary lymph node metastasis of breast cancer patient.
Methods: A retrospective cross-sectional diagnostic-accuracy study of 88 women with breast cancer who underwent MRI for axillary lymph node staging. MRI protocols included FD-MRI, non-contrast T1 sequence, and contrast-enhanced T1 sequence. Imaging findings, interpreted by two radiologists blinded to histopathological results, were correlated with findings from sentinel lymph node biopsy or axillary lymph node dissection as the gold standard. Data analysis comprised diagnostic performance parameters (sensitivity and specificity) and inter-protocol agreement using the kappa statistic.
Results: No statistically significant differences were detected among the three protocols (all McNemar's p-values > 0.05). The non-contrast abbreviated MRI protocol demonstrated a sensitivity of 84.9% (95% CI: 72.4%-93.3%) and a specificity of 85.7% (95% CI: 69.7%-95.2%). Unweighted Cohen’s Kappa demonstrated strong concordance between the non-contrast and contrast-enhanced AB-MRI protocols (κ = 0.931; 95% CI: 0.855–1.00), between the non-contrast AB-MRI protocol and the FD-MRI (κ = 0.930; 95% CI: 0.852–1.00), and between the contrast-enhanced AB-MRI protocol and the FD-MRI (κ = 0.907; 95% CI: 0.819–0.995), respectively.
Conclusion: Non-contrast AB-MRI provides a less invasive, cost-effective alternative to FD-MRI for staging axillary lymph nodes in breast cancer, with shorter scan times and fewer procedural risks. Further studies are needed for validation in larger cohorts.
Full text article
References
Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature medicine. 2025;31(4):1154-62. doi: 10.1038/s41591-025-03502-3.
Michaels E, Worthington RO, Rusiecki J. Breast Cancer: Risk Assessment, Screening, and Primary Prevention. The Medical clinics of North America. 2023;107(2):271-84. doi: 10.1016/j.mcna.2022.10.007.
Arslan G, Altintoprak KM, Yirgin IK, Atasoy MM, Celik L. Diagnostic accuracy of metastatic axillary lymph nodes in breast MRI. SpringerPlus. 2016;5(1):735. doi: 10.1186/s40064-016-2419-7.
Bode M, Schrading S, Masoumi A, Morscheid S, Schacht S, Dirrichs T, et al. Abbreviated MRI for Comprehensive Regional Lymph Node Staging during Pre-Operative Breast MRI. Cancers. 2023;15(6). doi: 10.3390/cancers15061859.
Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K. Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools. The oncologist. 2020;25(2):e231-e42. doi: 10.1634/theoncologist.2019-0427.
Kwon MR, Ko EY, Han BK, Ko ES, Choi JS, Park KW. Diagnostic performance of abbreviated breast MRI for screening of women with previously treated breast cancer. Medicine. 2020;99(16):e19676. doi: 10.1097/md.0000000000019676.
Mohammadzadeh S, Mohebbi A, Moradi Z, Ardakani AA, Mohammadi A, Tavangar SM. Comparing diagnostic performance of PET/CT, MRI, and CT in characterization of cN0 head and neck squamous cell carcinoma: A multicenter study. Radiography. 2025;31(2):102902. doi: https://doi.org/10.1016/j.radi.2025.102902.
Zeinalkhani F, Kamali Hakim P, Mahdavi Sabet F, Moradi Z, Rahmani Firouzi S, Zeinalkhani H, et al. Direct Comparison of Full Protocol MRI and Modified Non-Contrast MRI in Determination of Cancer Origin in Female Genital Tract Cancers: A Retrospective Study. Abdominal Radiology. 2025. doi: 10.1007/s00261-025-05291-2.
Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer. Radiology. 2017;283(2):361-70. doi: 10.1148/radiol.2016161444.
Tang WJ, Chen SY, Hu WK, Li XL, Zheng BJ, Wang ZS, et al. Abbreviated Versus Full-Protocol MRI for Breast Cancer Neoadjuvant Chemotherapy Response Assessment: Diagnostic Performance by General and Breast Radiologists. AJR American journal of roentgenology. 2023;220(6):817-25. doi: 10.2214/ajr.22.28686.
Cho P, Park CS, Park GE, Kim SH, Kim HS, Oh SJ. Diagnostic Usefulness of Diffusion-Weighted MRI for Axillary Lymph Node Evaluation in Patients with Breast Cancer. Diagnostics (Basel, Switzerland). 2023;13(3). doi: 10.3390/diagnostics13030513.
Cohen J. A Coefficient of Agreement for Nominal Scales. Educational and Psychological Measurement. 1960;20(1):37-46. doi: 10.1177/001316446002000104.
Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, et al. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Annals of oncology : official journal of the European Society for Medical Oncology. 2015;26(8):1533-46. doi: 10.1093/annonc/mdv221.
Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017;35(5):561-4. doi: 10.1200/jco.2016.71.0947.
Gera R, Kasem A, Mokbel K. Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice. In vivo (Athens, Greece). 2018;32(6):1301-7. doi: 10.21873/invivo.11380.
Pinheiro DJ, Elias S, Nazário AC. Axillary lymph nodes in breast cancer patients: sonographic evaluation. Radiologia brasileira. 2014;47(4):240-4. doi: 10.1590/0100-3984.2013.1689.
Chang JM, Leung JWT, Moy L, Ha SM, Moon WK. Axillary Nodal Evaluation in Breast Cancer: State of the Art. Radiology. 2020;295(3):500-15. doi: 10.1148/radiol.2020192534.
Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS. Abbreviated screening protocol for breast MRI: a feasibility study. Academic radiology. 2015;22(9):1157-62. doi: 10.1016/j.acra.2015.06.004.
Maung ST, Deepan N, Decharatanachart P, Chaiteerakij R. Abbreviated MRI for Hepatocellular Carcinoma Surveillance - A Systematic Review and Meta-analysis. Academic radiology. 2024;31(8):3142-56. doi: 10.1016/j.acra.2024.01.028.
Pesapane F, Battaglia O, Rotili A, Gnocchi G, D'Ecclesiis O, Bellerba F, et al. Comparative diagnostic efficacy of abbreviated and full protocol breast MRI: a systematic review and a meta-analysis. The British journal of radiology. 2024;97(1164):1915-24. doi: 10.1093/bjr/tqae196.
Hötker AM, Vargas HA, Donati OF. Abbreviated MR Protocols in Prostate MRI. Life (Basel, Switzerland). 2022;12(4). doi: 10.3390/life12040552.
Zeinalkhani F, Kamali Hakim P, Aghasi M, Mahdavi Sabet F, Mortazavi Ardestani R, Baghban Y, et al. Direct comparison of full protocol MRI and modified non-contrast MRI in staging of cervical cancer: a retrospective study. Abdominal Radiology. 2025. doi: 10.1007/s00261-025-05076-7.
Mohammadzadeh S, Mohebbi A, Moradi Z, Abdi A, Mohammadi A, Hakim PK, et al. Diagnostic performance of Kaiser score in the evaluation of breast cancer using MRI: A systematic review and meta-analysis. European journal of radiology. 2025;186:112055. doi: 10.1016/j.ejrad.2025.112055.
Kadioglu ME, Metin Y, Metin NO, Tasci F, Ozdemir O, Kupeli A. The efficacy of abbreviated breast MRI protocols using 1.5 T MRI in the preoperative staging of newly diagnosed breast cancers. Clinical imaging. 2023;101:44-9. doi: 10.1016/j.clinimag.2023.05.016.
Authors
Copyright (c) 2026 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.